Opinion|Videos|September 25, 2024
Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Key opinion leaders explore the significance of interdisciplinary collaboration in prostate cancer management, with a focus on how PSMA PET imaging enhances decision-making processes within multidisciplinary care teams.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How does PSMA PET imaging fit into the multidisciplinary approach to prostate cancer management, and what benefits and challenges arise when collaborating with other specialists to use its results for patient care?
- Have you observed any differences in the availability or accessibility of PSMA PET imaging based on geographical location or healthcare facility type?
Advertisement
Related to this article
Uptunity | Aneurysm reportedly identifies suspected saccular brain aneurysms larger than 3 mm on head CTA and provides quantitative comparison between exams to assess changes in known aneurysms over time.
Through enhanced insights into atherosclerotic disease, complex coronary lesions and coronary stents, photon-counting CT provides an anatomical roadmap that may improve outcomes for interventional procedures.
The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.
The mobile X-Ray unit DR 100s Pro reportedly offers an array of attributes to facilitate workflow efficiencies and quality imaging.
In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
A high glandular tissue component on pre-op breast ultrasound may significantly elevate the risk of recurrence for ipsilateral or contralateral breast cancer, according to a newly published study.
Effective January 1, 2027, use of the QTscan in outpatient diagnostic exams will be reimbursable with the CPT code 1079T.
In a recent interview, Carolynn DeBenedectis, MD, discussed the utility of AI-enabled slab reconstruction for interpretation of digital breast tomosynthesis (DBT) and new research showing a 13 percent reduction in reading time.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears CTA-Based AI Software for Brain Aneurysm Detection and Follow-Up
2
Will PCCT Lead the Next Revolution in Interventional Cardiology?
3
FDA Issues Breakthrough Therapy Designation for Emerging PSMA PET Agent in Men with Suspected PCa Recurrence
4
Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA
5